Protherics PLC announces - Holding(s) in Company 2
London, UK; Brentwood, TN, US; 20 November 2008 - Protherics PLC
("Protherics" or the "Company"), the international biopharmaceutical
company focused on critical care and cancer, announces that, on 19
November 2008, the following notification of interest in the ordinary
share capital of the Company was received from Aviva plc.